The U.S. is ready to roll out the COVID vaccine once it’s approved for kids age 5-11

. Justin Sullivan/Getty Images

hide caption

Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot center on Oct. 1, in San Rafael, Calif

toggle caption

Justin Sullivan/Getty Images

. Justin Sullivan/Getty Images

The vaccine could be cleared for usage in children ages 5 to 11 within a couple of weeks, officials stated. The FDAs independent advisory committee conference is arranged for Oct. 26, and the CDCs independent advisory committee conference is set for Nov. 2 and 3. The Pfizer vaccine currently has full approval for usage in grownups, and the federal government has actually licensed it for emergency use in children ages 12 to 17. White House authorities said they were announcing the plan to inoculate kids ages 5 to 11 before the vaccine was authorized for that age group so they might be “operationally all set” to release the doses as quickly as the approval came.

The White House stated on Wednesday that it is prepared to rapidly roll out COVID-19 vaccines for kids ages 5 to 11, if the Pfizer-BioNTech vaccine for that age group is licensed by the Food and Drug Administration and advised by the Centers for Disease Control and Prevention. The vaccine could be cleared for usage in kids ages 5 to 11 within a couple of weeks, officials said. White House officials stated they were revealing the strategy to inoculate children ages 5 to 11 prior to the vaccine was authorized for that age group so they might be “operationally ready” to release the doses as quickly as the approval came.

Under the plan, the administration will work with state and local leaders to make the vaccine available at more than 25,000 pediatricians workplaces and primary care websites and 100 kidss medical facility systems as well as pharmacies, schools and neighborhood health. The administration also will present a nationwide public education project to notify moms and dads and guardians about the vaccine and obtain concerns. U.S. Surgeon General Vivek Murthy said the project would assist avoid among the barriers to immunizing both adults and children– false information about the drug. “Thats why were making sure that its relied on messengers with clinical credibility who go out there and discuss these vaccines,” Murthy stated. “But it is our cumulative duty– whether were in government, in the media, whether were people– to help avoid the circulation and spread of misinformation online.”

Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot clinic on Oct. 1, in San Rafael, Calif

The White House stated on Wednesday that it is ready to rapidly roll out COVID-19 vaccines for kids ages 5 to 11, if the Pfizer-BioNTech vaccine for that age group is licensed by the Food and Drug Administration and recommended by the Centers for Disease Control and Prevention. The administration has actually bought enough doses for all 28 million kids in that age group and will provide it in smaller sized plans with necessary supplies like smaller sized needles to make it much easier to get to physicians, pediatricians and neighborhood university hospital, Biden administration officials stated. “Should the FDA and CDC license the vaccine, we will be prepared to get shots in arms,” stated White House coronavirus response organizer Jeff Zients throughout a news briefing Wednesday morning.

Leave a Reply

Your email address will not be published. Required fields are marked *